Contract Research & Services
Contract Research

Seamless Drug Development

Published 19 September 2014 | By PRA Health Sciences

The success rate of drug development has been studied extensively over the years and discussed in numerous publications. In an important recent paper by Hay et al (Nat Biotechnol. 2014;32:40-51), the overall likelihood of FDA approval for products entering clinical phase was estimated at approximately 10%.

Available Downloads

Seamless Drug Development